Pancreatic ductal adenocarcinoma resists chemotherapy, and most polymeric nanocarriers persist in tissue because their backbones cannot be degraded. This project will develop nanoparticles that co-del...

A U.S. trial testing a new oral therapy combo for pancreatic cancer is seeking participants with a specific genetic mutation called RAS G12D.

Gentle tumor dissociation and immunomagnetic isolation preserve surface antigens for downstream analysis.

Every October, Breast Cancer Awareness Month brings people around the world together under the pink ribbon to raise awareness, encourage early detection, support patients and fund research.

By today, systemic therapy for pancreatic cancer remains a huge challenge considering the last 10 years existing data. In 1997, gemcitabine emerged as a new reference treatment in advanced disease sta...

REGISTER NOW | Date: Wednesday 28 October 2026 | 8:00 PDT | 11:00 EDT | 15:00 GMT | 16:00 CET

Allegheny Health Network's Cancer Center contributed thousands of tests to an international pancreatic cancer research program. The results show promise for early detection.

YouTube video by WTAE-TV Pittsburgh

Vincent Chung, MD, spotlights the potential future of pancreatic cancer combination regimens, which may emerge from recent treatment paradigm updates, such as the FDA approval of daraxonrasib for pret...

Researchers are uncovering how metabolism may influence the way certain cancers grow and adapt.

University of Vermont-Sponsored IIT Explores TAMP in a New Clinical Setting: TAMP Utilization Prior to Surgical ResectionMOUNTAIN VIEW, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“Renov...

A Spanish AI company is using routine CT scans to spot pancreatic lesions earlier, aiming to help radiologists identify cases that might otherwise be missed.

About 8,000 new cases of pancreatic adenocarcinoma are diagnosed every year in France. The five-year overall survival does not exceed 5%. An efficient carcinologic surgery will not be possible for 80%...

Signal Transduction and Targeted Therapy - Gene-structured histology for deriving and predicting pancreatic cancer molecular subtypes

Researchers are uncovering how metabolism may influence the way certain cancers grow and adapt.

A new federal grant supports Dr. Wei Niu’s study of a genetic change in lab-grown miniature brains and how it may contribute to a rare type of epilepsy.

Background: Invasive lobular carcinoma (ILC) is a common histological subtype of breast cancer, yet preoperative axillary staging remains notoriously challenging due to its diffuse, infiltrative growt...

REDWOOD CITY, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innov...

Breakthrough pancreatic cancer drug daraxonrasib often loses effectiveness due to genetic changes, reveals studies from Dana-Farber and MD Anderson.

“The biggest question is: will we ever find a cure?” says Devalingam Mahalingam, MBBChBAO, PhD.

From his fourth-floor lab at the Technion-Israel Institute of Technology, Professor Ron Kimmel can see Haifa Bay, the green slopes of Mount Carmel and the distant hills of Galilee. But it’s the view o...

Oct. 1, 2026 — At ASTRO 2026 Elekta highlighted new data showing unprecedented long-term survival outcomes for patients with localized pancreatic cancer treated with high-dose, adaptive radiotherapy o...

2026 Grantee: Kazuki Sugahara, MD, PhD Columbia University Research Project: Tumor-penetrating stromal modification of ß5 integrin-rich pancreatic cancer Award: 2026 [...] READ MORE

A recent clinical trial conducted by researchers at Dana Farber Cancer Institute has explored a treatment strategy aimed at enhancing the effectiveness of

The pioneering study aims to look at a new way of preventing cancer for those with an inherited genetic risk

YouTube video by WFXR NEWS

Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion,...

In a poignant testament to the challenges surrounding pancreatic cancer, Charlotte Lynch, a senior policy advisor for a charity dedicated to the cause,

In a poignant testament to the challenges surrounding pancreatic cancer, Charlotte Lynch, a senior policy advisor for a charity dedicated to the cause,

Shalini V. Rao Will Join the CRUK Scotland Institute in early 2027 as a Junior Group Leader / cancer, Cancer Research UK Scotland Institute, CRUK Scotland

A new study from Mayo Clinic researchers suggests that an AI model could use routine electronic health records and laboratory data to identify people at higher risk of pancreatic cancer up to 5 years ...

Natalie's husband Craig Sullivan, from Nottinghamshire, has stage four pancreatic cancer.

A benefit for Griewahn scheduled for Sunday, Nov. 8, at the Swanton American Legion Post. It will include raffles, food, music and a silent auction.

Green Bay man survives two cancers and credits early detection and routine screenings for saving his life.

PQB-4, a fluorescent small-molecule ligand that targets c-MYC DNA G-quadruplexes (G4s), showed marked synergy with gemcitabine in resistant PANC-1 cells (CI = 0.027). In vivo, the ligand reduced tumo....

Reference #18.cc83017.1790986462.2d560422

YouTube video by WPLG Local 10

The Phase 3 PAPILLON study evaluated first-line amivantamab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer with EGFR Exon 20 insertion mutations. The ...

Japan approved Optune Pax plus gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancer.

Trusting off-the-shelf antibodies to do what the companies that sell them say they do should be a given – but it isn’t.

How a half century of basic science, public funding, and human persistence unlocked a way to target one of cancer’s most elusive drivers — and treat one of its deadliest cancers.